Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter's Triad): A systematic review of the literature

International Forum of Allergy and Rhinology

Volumn 3, Issue 11, 2013, Pages 915-920

  Xu, Jason J ^a   Sowerby, Leigh ^b   Rotenberg, Brian W ^b  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

ASA triad; Aspirin desensitization; Aspirin exacerbated respiratory disease; Nasal polyps; Samter's triad; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; LYSINE ACETYLSALICYLATE; MOMETASONE FUROATE;

ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; DESENSITIZATION; FOLLOW UP; HUMAN; NOSE POLYP; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHINOMANOMETRY; SELF REPORT; SYSTEMATIC REVIEW;

ASA TRIAD; ASPIRIN DESENSITIZATION; ASPIRIN EXACERBATED RESPIRATORY DISEASE; NASAL POLYPS; SAMTER'S TRIAD; SYSTEMATIC REVIEW;

ASPIRIN; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; NASAL POLYPS; TREATMENT OUTCOME;

EID: 84888031266     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21202     Document Type: Article

References (19)

1. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011;3(1):3-10.
2. White AA, Stevenson DD. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med. 2012;33:588-594.
3. Rotenberg BW, Zhang I, Arra I, Payton KB. Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial. Laryngoscope. 2011;121(12):2702-2705.
4. Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162-166.
5. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology Supplement. 2012(23):3 p preceding table of contents, 1-298.
6. Rosenfeld RM, et al. Clinical practice guideline: Adult sinusitis. Otolaryngology-Head and Neck Surgery. 2007;137:S1-S31.
7. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of epidemiology and community health. 1998;52(6):377-384.
8. Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2003;90(3):338-341.
9. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111(1):180-186.
10. Forer B, Kivity S, Sade J, Landsberg R. Aspirin desensitization for ASA triad patients-prospective study of the rhinologist's perspective. Rhinology. 2011;49(1):95-99.
11. Gosepath J, Schaefer D, Amedee RG, Mann WJ. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg. 2001;127(3):316-321.
12. Havel M, Ertl L, Braunschweig F, Markmann S, Leunig A, Gamarra F, et al. Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol. 2013;270(2):571-578.
13. Katial RK, Strand M, Prasertsuntarasai T, Leung R, Zheng W, Alam R. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol. 2010;126(4):738-744.
14. Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2007;119(1):157-164.
15. Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy. 2008;63(9):1228-1234.
16. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98(4):751-758.
17. Ogata N, Darby Y, Scadding G. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. J Laryngol Otol. 2007;121(12):1156-1160.
18. Parikh AA, Scadding GK. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope. 2005;115(8):1385-1390.
19. Nucera E, Schiavino D, Milani A, Del Ninno M, Misuraca C, Buonomo A, et al. Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies. Thorax. 2000;55(Suppl 2):S75-8.